News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
688,019 Results
Type
Article (39150)
Company Profile (283)
Press Release (648586)
Section
Business (203902)
Career Advice (1996)
Deals (35372)
Drug Delivery (89)
Drug Development (80852)
Employer Resources (168)
FDA (16099)
Job Trends (14808)
News (344645)
Policy (32450)
Tag
Academia (2530)
Alliances (49186)
Alzheimer's disease (1262)
Approvals (16060)
Artificial intelligence (145)
Bankruptcy (352)
Best Places to Work (11582)
Biotechnology (200)
Breast cancer (189)
Cancer (1375)
Cardiovascular disease (110)
Career advice (1664)
Cell therapy (281)
Clinical research (64707)
Collaboration (485)
Compensation (262)
COVID-19 (2541)
C-suite (109)
Data (1391)
Diabetes (176)
Diagnostics (6170)
Earnings (84895)
Employer resources (146)
Events (110014)
Executive appointments (397)
FDA (16785)
Funding (431)
Gene therapy (195)
GLP-1 (599)
Government (4333)
Healthcare (18697)
Infectious disease (2634)
Inflammatory bowel disease (111)
Interviews (309)
IPO (16344)
Job creations (3625)
Job search strategy (1418)
Layoffs (418)
Legal (7862)
Lung cancer (198)
Manufacturing (207)
Medical device (13213)
Medtech (13218)
Mergers & acquisitions (19195)
Metabolic disorders (460)
Neuroscience (1583)
NextGen Class of 2024 (6500)
Non-profit (4467)
Northern California (1700)
Obesity (262)
Opinion (183)
Parkinson's disease (98)
Patents (120)
People (56462)
Phase I (20127)
Phase II (28498)
Phase III (21240)
Pipeline (514)
Postmarket research (2560)
Preclinical (8545)
Radiopharmaceuticals (236)
Rare diseases (264)
Real estate (5890)
Regulatory (21679)
Research institute (2310)
Resumes & cover letters (349)
Southern California (1468)
Startups (3562)
United States (15234)
Vaccines (564)
Weight loss (182)
Date
Today (126)
Last 7 days (571)
Last 30 days (2374)
Last 365 days (35284)
2024 (35127)
2023 (40076)
2022 (51173)
2021 (55710)
2020 (54086)
2019 (46541)
2018 (35019)
2017 (32109)
2016 (31480)
2015 (37552)
2014 (31318)
2013 (26345)
2012 (28570)
2011 (29263)
2010 (27328)
Location
Africa (713)
Arizona (196)
Asia (37275)
Australia (6087)
California (3830)
Canada (1457)
China (307)
Colorado (172)
Connecticut (178)
Europe (79832)
Florida (537)
Georgia (136)
Illinois (387)
Indiana (225)
Maryland (634)
Massachusetts (2972)
Michigan (175)
Minnesota (291)
New Jersey (1108)
New York (1091)
North Carolina (743)
Northern California (1700)
Ohio (146)
Pennsylvania (928)
South America (1092)
Southern California (1468)
Texas (554)
Utah (108)
Washington State (401)
688,019 Results for "metacrine inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Deals
Metacrine and Equillium Mutually Agree to Terminate Definitive Merger Agreement
Metacrine, Inc. and Equillium, Inc. announced the mutual termination of their previously announced definitive merger agreement.
December 23, 2022
·
2 min read
Deals
Equillium and Metacrine Mutually Agree to Terminate Definitive Merger Agreement
Equillium, Inc. and Metacrine, Inc. announced the mutual termination of their previously announced definitive merger agreement.
December 23, 2022
·
5 min read
Business
Metacrine Reports Third-Quarter 2022 Results
Metacrine, Inc., a clinical-stage biopharmaceutical company developing differentiated therapies for patients with gastrointestinal diseases, reported its third-quarter 2022 financial results.
November 14, 2022
·
7 min read
Deals
Equillium to Acquire Metacrine in All-Stock Transaction
Equillium, Inc. and Metacrine Inc., announced that the two companies have entered into a definitive merger agreement pursuant to which Equillium will acquire Metacrine in an all-stock transaction.
September 6, 2022
·
13 min read
Business
Metacrine Reports Second-Quarter 2022 Results
Metacrine, Inc., a clinical-stage biopharmaceutical company pioneering differentiated therapies for patients with gastrointestinal diseases, reported its second-quarter 2022 financial results.
August 9, 2022
·
5 min read
Business
Metacrine Reports First-Quarter 2022 Results
Metacrine, Inc. reported its first-quarter 2022 financial results and provided a business update.
May 12, 2022
·
6 min read
Business
Metacrine Reports Fourth-Quarter 2021 Results
Metacrine, Inc., a clinical-stage biopharmaceutical company pioneering differentiated therapies for patients with gastrointestinal diseases, reported its fourth-quarter 2021 financial results.
March 30, 2022
·
5 min read
Business
Metacrine Announces Executive Leadership Changes
Metacrine, Inc., a clinical-stage biopharmaceutical company pioneering differentiated therapies for patients with gastrointestinal diseases, announced that Ms. Trisha Millican has resigned her position as chief financial officer.
February 24, 2022
·
2 min read
Business
Metacrine Announces Resignation of Chief Medical Officer
Metacrine, Inc. today announced that Hubert C. Chen, M.D., chief medical officer, has resigned to pursue a new opportunity.
December 27, 2021
·
2 min read
Press Releases
ABS Bio, Inc. announces strategic investment by 3 Boomerang Capital
◆Investment to support services growth. ◆Industry veterans join board of directors, including John Chickosky as Executive Chairman, and Greg Swanberg and Martin LeBlanc as Directors.
November 14, 2024
·
1 min read
1 of 68,802
Next
